Fundraising Fox

Longwood Fund2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Neela TherapeuticsNov 2025SEC filingmedium confidence

HealthtechLunenburg, US

PJ Anand(Executive Officer, Director)

BoardRichard Upton(Director)Edgar D. Jannotta Jr.(Director)Norbert Riedel(Director)Stephen Oesterle(Director)

Board seatDavid Donabedian· per SEC Form D · $21.5M raise · filed May 2026

Newleos Therapeuticsnewleostherapeutics.cominFeb 2025 · $93.5M

BiotechBoston, US

David Donabedian(Executive Officer, Director)Robert Hadfield(Executive Officer)inJohn McCabe(Executive Officer)in

BoardMing Cheah(Director)Raymond Camahort(Director)

Board seatChristoph Westphal· per SEC Form D

Co-investorsDCVC (Data Collective)DCVC BioNovo Holdings

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.